$HHS
HARTE HANKS INC Stock $hhs

$hhs Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000143774922006846 Filed on March 21, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$51.99M	$194.6M	$47.08M
YoY Change	10.43%	10.0%	-10.04%
Cost Of Revenue	$42.42M	$160.2M	$39.42M
YoY Change	7.61%	4.72%	-13.52%
Gross Profit	$9.563M	$34.42M	$7.651M
YoY Change	24.99%	43.79%	13.55%
Gross Profit Margin	18.4%	17.69%	16.25%
Selling, General & Admin	$4.630M	$17.86M	$5.940M
YoY Change	-22.05%	-17.02%	46.05%
% of Gross Profit	48.42%	51.89%	77.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$591.0K	$2.559M	$710.0K
YoY Change	-16.76%	-29.21%	-46.17%
% of Gross Profit	6.18%	7.44%	9.28%
Operating Expenses	$5.221M	$178.0M	$6.650M
YoY Change	-21.49%	2.04%	23.51%
Operating Profit	$4.342M	$7.639M	$1.001M
YoY Change	333.77%	-172.23%	-26.07%
Interest Expense	-$258.0K	-$903.0K	-$282.0K
YoY Change	-8.51%	-22.42%	-12.96%
% of Operating Profit	-5.94%	-11.82%	-28.17%
Other Income/Expense, Net	-$579.0K	$8.620M	-$2.058M
YoY Change	-71.87%	-211.47%	-20.91%
Pretax Income	$2.026M	$16.26M	-$2.708M
YoY Change	-174.82%	-188.8%	33.2%
Income Tax	$270.0K	$1.288M	-$3.752M
% Of Pretax Income	13.33%	7.92%
Net Earnings	$1.756M	$14.97M	$1.044M
YoY Change	68.2%	-983.77%	-135.44%
Net Earnings / Revenue	3.38%	7.69%	2.22%
Basic Earnings Per Share		$1.85
Diluted Earnings Per Share	$238.0K	$1.76	$161.4K
COMMON SHARES
Basic Shares Outstanding	6.976M	6.802M
Diluted Shares Outstanding		7.209M

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.91M	$11.91M	$29.41M
YoY Change	-59.5%	-59.5%	4.64%
Cash & Equivalents	$11.91M	$11.91M	$29.41M
Short-Term Investments
Other Short-Term Assets	$1.031M	$13.66M	$886.0K
YoY Change	16.37%	-6.7%	-46.95%
Inventory			$46.00K
Prepaid Expenses	$1.948M		$2.256M
Receivables	$41.05M	$49.81M	$36.02M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$75.38M	$75.38M	$86.24M
YoY Change	-12.6%	-12.6%	8.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.747M	$29.89M	$5.878M
YoY Change	31.8%	-2.41%	-29.38%
Goodwill	$0.00
YoY Change
Intangibles	$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.597M	$2.597M	$2.632M
YoY Change	-1.33%	-1.33%	-30.02%
Total Long-Term Assets	$32.49M	$32.49M	$33.26M
YoY Change	-2.33%	-2.33%	7.63%
TOTAL ASSETS
Total Short-Term Assets	$75.38M	$75.38M	$86.24M
Total Long-Term Assets	$32.49M	$32.49M	$33.26M
Total Assets	$107.9M	$107.9M	$119.5M
YoY Change	-9.74%	-9.74%	8.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$16.13M	$16.13M	$16.29M
YoY Change	-0.99%	-0.99%	-3.68%
Accrued Expenses	$13.39M	$13.39M	$11.68M
YoY Change	14.58%	14.58%	2.12%
Deferred Revenue	$3.942M		$4.661M
YoY Change	-15.43%		6.0%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$194.0K	$4.926M
YoY Change	-100.0%	-96.24%
Total Short-Term Liabilities	$42.44M	$42.44M	$47.19M
YoY Change	-10.07%	-10.07%	3.65%
LONG-TERM LIABILITIES
Long-Term Debt	$5.000M	$5.211M	$22.17M
YoY Change	-77.45%	-76.92%	18.58%
Other Long-Term Liabilities	$3.697M	$75.20M	$4.747M
YoY Change	-22.12%	-19.25%	81.95%
Total Long-Term Liabilities	$8.697M	$80.41M	$26.92M
YoY Change	-67.69%	-30.5%	26.34%
TOTAL LIABILITIES
Total Short-Term Liabilities	$42.44M	$42.44M	$47.19M
Total Long-Term Liabilities	$8.697M	$80.41M	$26.92M
Total Liabilities	$122.9M	$122.9M	$162.9M
YoY Change	-24.58%	-24.58%	8.48%
SHAREHOLDERS EQUITY
Retained Earnings	$811.1M		$796.1M
YoY Change	1.88%		-0.21%
Common Stock	$302.8M		$395.2M
YoY Change	-23.37%		-13.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.085B		$1.179B
YoY Change	-7.93%		-5.2%
Treasury Stock Shares	$5.145M		$5.522M
Shareholders Equity	-$24.72M	-$14.99M	-$53.12M
YoY Change
Total Liabilities & Shareholders Equity	$107.9M	$107.9M	$119.5M
YoY Change	-9.74%	-9.74%	8.44%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	$1.756M	$14.97M	$1.044M
YoY Change	68.2%	-983.77%	-135.44%
Depreciation, Depletion And Amortization	$591.0K	$2.559M	$710.0K
YoY Change	-16.76%	-29.21%	-46.17%
Cash From Operating Activities	$4.175M	-$1.763M	$3.593M
YoY Change	16.2%	-77.51%	32.0%
INVESTING ACTIVITIES
Capital Expenditures	-$568.0K	$3.046M	-$1.325M
YoY Change	-57.13%	12.86%	6.85%
Acquisitions		$0.00
YoY Change
Other Investing Activities	$45.00K	$146.0K	$33.00K
YoY Change	36.36%	-92.41%	-88.42%
Cash From Investing Activities	-$523.0K	-$2.900M	-$1.292M
YoY Change	-59.52%	274.19%	35.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-8.568M	-$13.41M	-199.0K
YoY Change	4205.53%	-283.41%	-42.49%
NET CHANGE
Cash From Operating Activities	4.175M	-$1.763M	3.593M
Cash From Investing Activities	-523.0K	-$2.900M	-1.292M
Cash From Financing Activities	-8.568M	-$13.41M	-199.0K
Net Change In Cash	-4.916M	-$18.43M	2.102M
YoY Change	-333.87%	3190.89%	47.92%
FREE CASH FLOW
Cash From Operating Activities	$4.175M	-$1.763M	$3.593M
Capital Expenditures	-$568.0K	$3.046M	-$1.325M
Free Cash Flow	$4.743M	-$4.809M	$4.918M
YoY Change	-3.56%	-54.37%	24.13%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Auditor Location AuditorLocation	Tewksbury, Massachusetts
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	266000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	241000	USD
CY2021Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	1
CY2020Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	1
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12121484
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12121484
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6976144
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6599309
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	5145340
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	5522175
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	pure
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1948000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2256000	USD
CY2021Q4	hrth	Prepaid Taxes And Income Taxes Receivable Current PrepaidTaxesAndIncomeTaxesReceivableCurrent	7456000	USD
CY2021	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	76.80
CY2021	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	115.20
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0
CY2021	hrth	Defined Benefit Plan Period Of Operating History And Sufficient Trading Volume Of Invested Entity DefinedBenefitPlanPeriodOfOperatingHistoryAndSufficientTradingVolumeOfInvestedEntity	P5Y
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11911000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29408000	USD
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	3222000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	4154000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	41051000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	36023000	USD
CY2021Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	8134000	USD
CY2020Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	5510000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	622000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	613000	USD
CY2020Q4	hrth	Prepaid Taxes And Income Taxes Receivable Current PrepaidTaxesAndIncomeTaxesReceivableCurrent	7388000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1031000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	886000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	75375000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	86238000	USD
CY2021Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	6430000	USD
CY2020Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	8882000	USD
CY2021Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	21189000	USD
CY2020Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	33650000	USD
CY2021Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	29949000	USD
CY2020Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	32693000	USD
CY2021Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	2691000	USD
CY2020Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	315000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	60259000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	75540000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	52512000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	69662000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7747000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5878000	USD
CY2021Q4	hrth	Lease Rightofuse Asset LeaseRightofuseAsset	22142000	USD
CY2020Q4	hrth	Lease Rightofuse Asset LeaseRightofuseAsset	24750000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2597000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2632000	USD
CY2021Q4	us-gaap	Assets Assets	107861000	USD
CY2020Q4	us-gaap	Assets Assets	119498000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	16132000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	16294000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7028000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5248000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	4926000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3942000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4661000	USD
CY2021Q4	hrth	Customer Postage And Program Deposits Current CustomerPostageAndProgramDepositsCurrent	6496000	USD
CY2020Q4	hrth	Customer Postage And Program Deposits Current CustomerPostageAndProgramDepositsCurrent	6497000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2291000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2903000	USD
CY2021Q4	hrth	Lease Liability Current LeaseLiabilityCurrent	6553000	USD
CY2020Q4	hrth	Lease Liability Current LeaseLiabilityCurrent	6663000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	42442000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	47192000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	12121000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5000000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	22174000	USD
CY2021Q4	hrth	Lease Liability Noncurrent LeaseLiabilityNoncurrent	19215000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	290711000	USD
CY2020Q4	hrth	Lease Liability Noncurrent LeaseLiabilityNoncurrent	21295000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3697000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4747000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	122853000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	162898000	USD
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	9723000	USD
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	9723000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	12121000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	383043000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	811094000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	796123000	USD
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1085313000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1178799000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-53328000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-65611000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-24715000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-53123000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	107861000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	119498000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	194596000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	176900000	USD
CY2021	us-gaap	Labor And Related Expense LaborAndRelatedExpense	109917000	USD
CY2020	us-gaap	Labor And Related Expense LaborAndRelatedExpense	103675000	USD
CY2021	us-gaap	Production And Distribution Costs ProductionAndDistributionCosts	50264000	USD
CY2020	us-gaap	Production And Distribution Costs ProductionAndDistributionCosts	49290000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	17858000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	21522000	USD
CY2021	us-gaap	Restructuring Charges RestructuringCharges	6359000	USD
CY2020	us-gaap	Restructuring Charges RestructuringCharges	9374000	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2559000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3615000	USD
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	186957000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	187476000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	7639000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-10576000	USD
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-903000	USD
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1164000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	10000000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-477000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6569000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	8620000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7733000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	16259000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18309000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1288000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-16615000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	14971000	USD
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.76
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-1694000	USD
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	496000	USD
CY2020	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	496000	USD
CY2021	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	1858000	USD
CY2020	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	12617000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2190000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.85
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6802000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6469000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7209000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6469000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	14971000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-1694000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax	14150000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax	-4657000	USD
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1867000	USD
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2180000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	12283000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2477000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	27254000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4171000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-49683000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	753000	USD
CY2020	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	-22000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-1694000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2477000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-53123000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	94000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1445000	USD
CY2021	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	-385000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	14971000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	12283000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-24715000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	14971000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-1694000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2559000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3615000	USD
CY2021	us-gaap	Restructuring Costs RestructuringCosts	913000	USD
CY2020	us-gaap	Restructuring Costs RestructuringCosts	3195000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1469000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	764000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	10000000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	USD
CY2021	us-gaap	Pension Expense Reversal Of Expense Noncash PensionExpenseReversalOfExpenseNoncash	-717000	USD
CY2020	us-gaap	Pension Expense Reversal Of Expense Noncash PensionExpenseReversalOfExpenseNoncash	-7134000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-244000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9175000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	931000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-925000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3469000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1763000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7840000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3046000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2699000	USD
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	146000	USD
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1924000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2900000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-775000	USD
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	5000000	USD
CY2020	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	10000000	USD
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	17100000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-395000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-997000	USD
CY2021	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-2313000	USD
CY2020	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-945000	USD
CY2020	us-gaap	Repayments Of Debt RepaymentsOfDebt	1600000	USD
CY2021	us-gaap	Payments Of Debt Restructuring Costs PaymentsOfDebtRestructuringCosts	795000	USD
CY2020	us-gaap	Payments Of Debt Restructuring Costs PaymentsOfDebtRestructuringCosts	653000	USD
CY2021	hrth	Finance Lease Payments Including Shortterm Leases FinanceLeasePaymentsIncludingShorttermLeases	227000	USD
CY2020	hrth	Finance Lease Payments Including Shortterm Leases FinanceLeasePaymentsIncludingShorttermLeases	412000	USD
CY2021	hrth	Proceeds From Payments For Issuance Of Treasury Stock ProceedsFromPaymentsForIssuanceOfTreasuryStock	-291000	USD
CY2020	hrth	Proceeds From Payments For Issuance Of Treasury Stock ProceedsFromPaymentsForIssuanceOfTreasuryStock	-22000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-13413000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7313000	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-353000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	742000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-18429000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-560000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33562000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34122000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15133000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33562000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	490000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	652000	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1323000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	9216000	USD
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2715000	USD
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1965000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	540000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	266000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	241000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	194596000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	176900000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7747000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5878000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b/></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Use of Estimates</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b> </b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from those estimates due to uncertainties. Such estimates in<span style="background-color:#ffffff;">clude, but </span>are <em style="font: inherit;">not</em> limited to, estimates related to lease accounting; pension accounting; fair value for purposes of assessing long-lived assets for impairment; revenue recognition; income taxes; stock-based compensation and contingencies. On an ongoing basis, management reviews its estimates and assumptions based on currently available information. Changes in facts and circumstances could result in revised estimates and assumptions.</p>
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	70000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	241000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	666000	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	95000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	115000	USD
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	200000	USD
CY2020	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	800000	USD
CY2021Q4	hrth	Deductible For Individual Health Care Claims DeductibleForIndividualHealthCareClaims	300000	USD
CY2021Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	1200000	USD
CY2020Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	1400000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	194596000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	176900000	USD
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	622000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	613000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3942000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4661000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	756000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	817000	USD
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4200000	USD
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4500000	USD
CY2021Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	1500000	USD
CY2020Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	1300000	USD
CY2021	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	800000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	21400000	USD
CY2021Q4	hrth	Finance Lease Rightof Use Asset Accumulated Depreciation FinanceLeaseRightofUseAssetAccumulatedDepreciation	700000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	8229000	USD
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	1000000.0	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	23800000	USD
CY2020Q4	hrth	Finance Lease Rightof Use Asset Accumulated Depreciation FinanceLeaseRightofUseAssetAccumulatedDepreciation	500000	USD
CY2021Q4	hrth	Lease Rightofuse Asset LeaseRightofuseAsset	22142000	USD
CY2020Q4	hrth	Lease Rightofuse Asset LeaseRightofuseAsset	24750000	USD
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	7745000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	8646000	USD
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	195000	USD
CY2020	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	240000	USD
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	27000	USD
CY2020	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	45000	USD
CY2021	hrth	Finance Lease Cost FinanceLeaseCost	222000	USD
CY2020	hrth	Finance Lease Cost FinanceLeaseCost	285000	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	2604000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	3085000	USD
CY2021	us-gaap	Sublease Income SubleaseIncome	1153000	USD
CY2020	us-gaap	Sublease Income SubleaseIncome	470000	USD
CY2021	us-gaap	Lease Cost LeaseCost	9418000	USD
CY2020	us-gaap	Lease Cost LeaseCost	11546000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	15287000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	18777000	USD
CY2021	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	25000	USD
CY2020	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	40000	USD
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	227000	USD
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	412000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y1M28D
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y18D
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y1M28D
CY2020Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y11M19D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0345	pure
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0372	pure
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0541	pure
CY2020Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0674	pure
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	6510000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	209000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	5285000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	167000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	3856000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	48000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2119000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	6000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	2014000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	0	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	28013000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	430000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2650000	USD
CY2021Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	25000	USD
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	405000	USD
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	700000	USD
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	200000	USD
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000.0
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	5000000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	27100000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	-0	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	4926000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5000000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	22174000	USD
CY2021Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	0	USD
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	500000	USD
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	700000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1500000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	800000	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	126696
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	57.48
CY2020	hrth	Sharebased Compensation Arrangement By Sharebased Payment Award Options Adjustment And Correction SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAdjustmentAndCorrection	7500
CY2020	hrth	Sharebased Compensation Arrangement By Sharebased Payment Award Options Adjustment And Correction Weighted Average Exercise Price Ending Balance SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAdjustmentAndCorrectionWeightedAverageExercisePriceEndingBalance	53.61
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	-0
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	31449
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	90.89
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	87747
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	40.25
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	31906
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.95
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	7411
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	7.40
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	10815
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	37.87
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	37615
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	80.21
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y4M9D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	37615
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	80.21
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P1Y4M9D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	37615
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	80.21
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y4M9D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2021Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	37615
CY2021Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	80.21
CY2021	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P1Y4M9D
CY2021Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	37615
CY2021Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	80.21
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	8032
CY2021Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	131741000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Weighted Average Asset Allocations DefinedBenefitPlanWeightedAverageAssetAllocations	1	pure
CY2020Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	129348000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Weighted Average Asset Allocations DefinedBenefitPlanWeightedAverageAssetAllocations	1	pure
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths	10973000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Two DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo	11181000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Three DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree	11296000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Four DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour	11364000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Five DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive	11486000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter	57435000	USD
CY2021Q4	hrth	Defined Benefit Plan Expected Future Benefit Payments DefinedBenefitPlanExpectedFutureBenefitPayments	113735000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-372000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-17286000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	856000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	696000	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	804000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	219000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1288000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-16371000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1398000	USD
CY2020	hrth	Income Tax Rate Reconciliation Gain Loss On Ppp Loan Forgiveness IncomeTaxRateReconciliationGainLossOnPPPLoanForgiveness	0	USD
CY2021	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	403000	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	-0	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2163000	USD
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	521000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-244000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1288000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-16615000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	11725000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-20683000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	4534000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	2374000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	16259000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18309000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	3413000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3845000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	172000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	0	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	520000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-223000	USD
CY2021	hrth	Effective Income Tax Rate Reconciliation Foreign Subsidiary Dividend Inclusions EffectiveIncomeTaxRateReconciliationForeignSubsidiaryDividendInclusions	447000	USD
CY2020	hrth	Effective Income Tax Rate Reconciliation Foreign Subsidiary Dividend Inclusions EffectiveIncomeTaxRateReconciliationForeignSubsidiaryDividendInclusions	1208000	USD
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-224000	USD
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	281000	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1424000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-7538000	USD
CY2021	hrth	Effective Income Tax Rate Reconciliation Cares Act Net Operating Loss Carryforwards Carryback Amount EffectiveIncomeTaxRateReconciliationCARESActNetOperatingLossCarryforwardsCarrybackAmount	-343000	USD
CY2020	hrth	Effective Income Tax Rate Reconciliation Cares Act Net Operating Loss Carryforwards Carryback Amount EffectiveIncomeTaxRateReconciliationCARESActNetOperatingLossCarryforwardsCarrybackAmount	-6816000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-244000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	296000	USD
CY2021	hrth	Effective Income Tax Rate Reconciliation Return To Provision Amount EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount	247000	USD
CY2020	hrth	Effective Income Tax Rate Reconciliation Return To Provision Amount EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount	0	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-373000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	USD
CY2021	hrth	Effective Income Tax Rate Reconciliation Adjustments To State Attributes EffectiveIncomeTaxRateReconciliationAdjustmentsToStateAttributes	1561000	USD
CY2020	hrth	Effective Income Tax Rate Reconciliation Adjustments To State Attributes EffectiveIncomeTaxRateReconciliationAdjustmentsToStateAttributes	0	USD
CY2021	hrth	Income Tax Rate Reconciliation Gain Loss On Ppp Loan Forgiveness IncomeTaxRateReconciliationGainLossOnPPPLoanForgiveness	-2122000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	6746000	USD
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	61000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	22000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1288000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-16615000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1288000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-16615000	USD
CY2021	us-gaap	Income Tax Effects Allocated Directly To Equity IncomeTaxEffectsAllocatedDirectlyToEquity	0	USD
CY2020	us-gaap	Income Tax Effects Allocated Directly To Equity IncomeTaxEffectsAllocatedDirectlyToEquity	0	USD
CY2021	us-gaap	Income Tax Expense Benefit Intraperiod Tax Allocation IncomeTaxExpenseBenefitIntraperiodTaxAllocation	1288000	USD
CY2020	us-gaap	Income Tax Expense Benefit Intraperiod Tax Allocation IncomeTaxExpenseBenefitIntraperiodTaxAllocation	-16615000	USD
CY2021	hrth	Expected Proceeds From Income Tax Refunds Carryback Of Loss ExpectedProceedsFromIncomeTaxRefundsCarrybackOfLoss	17400000	USD
CY2021	hrth	Proceeds From Income Tax Refunds Cares Act ProceedsFromIncomeTaxRefundsCARESAct	9600000	USD
CY2021Q4	hrth	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation And Postretirement Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensationAndPostretirementBenefits	13135000	USD
CY2020Q4	hrth	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation And Postretirement Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensationAndPostretirementBenefits	16541000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	181000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	237000	USD
CY2021Q4	hrth	Deferred Tax Assets Leases Liability DeferredTaxAssetsLeasesLiability	5873000	USD
CY2020Q4	hrth	Deferred Tax Assets Leases Liability DeferredTaxAssetsLeasesLiability	6346000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	385000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	440000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	96000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	108000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	59000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	53000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Investment In Subsidiaries DeferredTaxAssetsInvestmentInSubsidiaries	1019000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Investment In Subsidiaries DeferredTaxAssetsInvestmentInSubsidiaries	1124000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	473000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	581000	USD
CY2021Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	1267000	USD
CY2020Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	1530000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	452000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	440000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	1631000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	1771000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	3475000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	4763000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	3841000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	3653000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	215000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	32102000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	37587000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	25894000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	30841000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	6208000	USD
CY2021Q4	hrth	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	5006000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	6746000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	897000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	625000	USD
CY2020Q4	hrth	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	5583000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	305000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	318000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	-0	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	-0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	38379000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	220000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	6208000	USD
CY2020	hrth	Valuation Allowance Deferred Tax Asset Deferred Income Tax Expense Benefit ValuationAllowanceDeferredTaxAssetDeferredIncomeTaxExpenseBenefit	-7534000	USD
CY2020	hrth	Valuation Allowance Deferred Tax Asset Return To Provision Impact ValuationAllowanceDeferredTaxAssetReturnToProvisionImpact	-12000	USD
CY2020	hrth	Valuation Allowance Deferred Tax Asset Other Comprehensive Income ValuationAllowanceDeferredTaxAssetOtherComprehensiveIncome	-16000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	30841000	USD
CY2021	hrth	Valuation Allowance Deferred Tax Asset Deferred Income Tax Expense Benefit ValuationAllowanceDeferredTaxAssetDeferredIncomeTaxExpenseBenefit	-1460000	USD
CY2021	hrth	Valuation Allowance Deferred Tax Asset Return To Provision Impact ValuationAllowanceDeferredTaxAssetReturnToProvisionImpact	297000	USD
CY2021	hrth	Valuation Allowance Deferred Tax Asset Other Comprehensive Income ValuationAllowanceDeferredTaxAssetOtherComprehensiveIncome	-3190000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	25894000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	25900000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	30800000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	14971000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-1694000	USD
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	496000	USD
CY2020	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	496000	USD
CY2021	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	1858000	USD
CY2020	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	12617000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2190000	USD
CY2021	us-gaap	Dilutive Securities DilutiveSecurities	1858000	USD
CY2020	us-gaap	Dilutive Securities DilutiveSecurities	0	USD
CY2021	hrth	Re Allocation Of Earnings To Participating Securities Considering Potentially Dilutive Securities ReAllocationOfEarningsToParticipatingSecuritiesConsideringPotentiallyDilutiveSecurities	1766000	USD
CY2020	hrth	Re Allocation Of Earnings To Participating Securities Considering Potentially Dilutive Securities ReAllocationOfEarningsToParticipatingSecuritiesConsideringPotentiallyDilutiveSecurities	-0	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	12709000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2190000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6802000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6469000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7209000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6469000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.85
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.76
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2021Q4	us-gaap	Litigation Reserve LitigationReserve	0	USD
CY2021	us-gaap	Restructuring Charges RestructuringCharges	6400000	USD
CY2020	us-gaap	Restructuring Charges RestructuringCharges	9400000	USD
CY2021	us-gaap	Restructuring Charges RestructuringCharges	6359000	USD
CY2020	us-gaap	Restructuring Charges RestructuringCharges	9374000	USD
CY2021	us-gaap	Revenues Revenues	194596000	USD
CY2020Q4	us-gaap	Restructuring Reserve RestructuringReserve	553000	USD
CY2021	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	2480000	USD
CY2021	us-gaap	Payments For Restructuring PaymentsForRestructuring	2295000	USD
CY2021Q4	us-gaap	Restructuring Reserve RestructuringReserve	738000	USD
CY2021Q4	us-gaap	Restructuring And Related Cost Expected Cost1 RestructuringAndRelatedCostExpectedCost1	27600000	USD
CY2021	us-gaap	Restructuring Charges RestructuringCharges	6400000	USD
CY2020	us-gaap	Restructuring Charges RestructuringCharges	9400000	USD
CY2019	us-gaap	Restructuring Charges RestructuringCharges	11800000	USD
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	pure
CY2021	us-gaap	Operating Expenses OperatingExpenses	178039000	USD
CY2021	us-gaap	Restructuring Charges RestructuringCharges	6359000	USD
CY2021	hrth	Contribution Margin ContributionMargin	10198000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold Overhead CostOfGoodsAndServicesSoldOverhead	0	USD
CY2021	hrth	Ebitda EBITDA	10198000	USD
CY2021	us-gaap	Depreciation Depreciation	2559000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	7639000	USD
CY2020	us-gaap	Revenues Revenues	176900000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	174487000	USD
CY2020	us-gaap	Restructuring Charges RestructuringCharges	9374000	USD
CY2020	hrth	Contribution Margin ContributionMargin	-6961000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold Overhead CostOfGoodsAndServicesSoldOverhead	0	USD
CY2020	hrth	Ebitda EBITDA	-6961000	USD
CY2020	us-gaap	Depreciation Depreciation	3615000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-10576000	USD

Files In Submission

Name	View Source	Status
0001437749-22-006846-index-headers.html	Edgar Link	pending
R4.htm	Edgar Link	pending
0001437749-22-006846-index.html	Edgar Link	pending
0001437749-22-006846.txt	Edgar Link	pending
0001437749-22-006846-xbrl.zip	Edgar Link	pending
ex_313888.htm	Edgar Link	pending
ex_313888img001.gif	Edgar Link	pending
ex_313889.htm	Edgar Link	pending
ex_313890.htm	Edgar Link	pending
ex_313891.htm	Edgar Link	pending
ex_313892.htm	Edgar Link	pending
ex_313893.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hrth-20211231.xsd	Edgar Link	pending
hrth-20211231_cal.xml	Edgar Link	unprocessable
hrth-20211231_def.xml	Edgar Link	unprocessable
hrth-20211231_lab.xml	Edgar Link	unprocessable
hrth-20211231_pre.xml	Edgar Link	unprocessable
hrth20211231b_10k.htm	Edgar Link	pending
hrth20211231b_10k_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
updtdlogo.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HHS
HARTE HANKS INC Stock $hhs

2021 Q4 Form 10-K Financial Statement

#000143774922006846 Filed on March 21, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HHS HARTE HANKS INC Stock $hhs

2021 Q4 Form 10-K Financial Statement

#000143774922006846 Filed on March 21, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HHS
HARTE HANKS INC Stock $hhs